SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-14-000345
Filing Date
2014-05-05
Accepted
2014-05-05 17:28:50
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q regen5514form10q.htm 10-Q 297551
2 EXHIBIT 31.1 regen5514exh31_1.htm EX-31.1 8078
3 EXHIBIT 31.2 regen5514exh31_2.htm EX-31.2 8295
4 EXHIBIT 32.1 regen5514exh32_1.htm EX-32.1 5174
5 EXHIBIT 32.2 regen5514exh32_2.htm EX-32.2 5178
  Complete submission text file 0001554795-14-000345.txt   1264588

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE regen-20140331.xml EX-101.INS 86181
7 XBRL SCHEMA FILE regen-20140331.xsd EX-101.SCH 12233
8 XBRL CALCULATION FILE regen-20140331_cal.xml EX-101.CAL 14154
9 XBRL DEFINITION FILE regen-20140331_def.xml EX-101.DEF 8902
10 XBRL LABEL FILE regen-20140331_lab.xml EX-101.LAB 82596
11 XBRL PRESENTATION FILE regen-20140331_pre.xml EX-101.PRE 63403
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 14814665
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences